EX-32.2 9 b400211ex32_2.htm EXHIBIT 32.2 Prepared and filed by St Ives Burrups

Exhibit 32.2

STATEMENT PURSUANT TO 18 U.S.C. §1350

Pursuant to 18 U.S.C. §1350, the undersigned certifies that this Quarterly Report on Form 10-Q for the period ended June 30, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Savient Pharmaceuticals, Inc.

August 9, 2004 By: /s/ Alan Rubinfeld
   
    Alan Rubinfeld
    Acting Chief Financial Officer and Treasurer